Tradestie Institutional Equity Comparison Engine
DNTH vs NTLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DNTH Overall Edge
DNTH Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DNTH trades at N/M Forward P/E with -8683.9% operating margin (+205.6% YoY revenue) versus NTLA at N/M Forward P/E and -826.0% operating margin (-48.0% YoY). In options structure, DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
DNTH N/M vs NTLA N/M Fwd P/E
Growth & Margin Winner
DNTH
Op Margin -8683.9% vs -826.0% ยท YoY +205.6% vs -48.0%
Momentum & Technical Winner
DNTH
1Y +149.5% vs +15.3% ยท 52W Pos 65% vs 20%
Options & Structure Winner
DNTH
CONSOLIDATION (7th %ile IV) vs BREAKDOWN (78th %ile IV)
DNTH
NASDAQ
Dianthus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$88.58
-3.52% 1D
Market Cap
$5.2B
1M Return
+22.87%
1Y Return
+149.51%
Forward P/E
N/M
Unified AI Score
34.1 / 100
SELL
Tech 8.0
Fund 43.0
Flow 68.0
Mom 64.0
NTLA
NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap
$1.5B
1M Return
-12.43%
1Y Return
+15.34%
Forward P/E
N/M
Unified AI Score
50.7 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 59.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DNTH +149.51%
NTLA +15.34%
Spread: +134.17 pp (DNTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DNTH Revenue | NTLA Revenue | DNTH Op. Margin | NTLA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $30M | N/A | -298.6% | NTLA |
| FY2019 | N/A | $40M | N/A | -246.8% | NTLA |
| FY2020 | N/A | $60M | N/A | -235.5% | NTLA |
| FY2021 | N/A | $30M | N/A | -810.4% | NTLA |
| FY2022 | N/A | $50M | N/A | -879.0% | NTLA |
| FY2023 | $0M | $40M | -1704.7% | -1420.5% | NTLA |
| FY2024 | $10M | $60M | -1633.7% | -923.1% | NTLA |
| FY2025 | $0M | $70M | -8739.3% | -651.7% | NTLA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DNTH | NTLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $1.5B | Larger Scale | DNTH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +205.6% | -48.0% | Higher Growth | DNTH |
| Operating Margin (TTM) Profitability | -8683.9% | -826.0% | Higher Margin | NTLA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -22.6% | -62.6% | Higher ROE | DNTH |
| 52-Week Range Position Momentum | 65% ($34โ$118) | 20% ($8โ$18) | Stronger Trend | DNTH |
| Beta / 30D Volatility Risk Regime | 1.03ฮฒ ยท 41% Vol | 2.30ฮฒ ยท 87% Vol | Lower Realized Risk | DNTH |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 50.7 / 100 (HOLD) | Higher Composite | NTLA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DNTH vs NTLA Buy Guide
DNTH
CONSOLIDATION
149d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
NTLA
BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
78th %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DNTH nor NTLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.